Tenaya Therapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Tenaya Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-06-30 was $29.00K, a 3.57% increase year-over-year.
- Tenaya Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $28.00K, a 9.68% decline year-over-year.
- Tenaya Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-03-31 was $17.00K, a 41.38% decline year-over-year.
- Tenaya Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-09-30 was $268.00K, a 2133.33% increase year-over-year.
- Tenaya Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $358.00K, a 952.94% increase from fiscal 2020.
- Tenaya Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $34.00K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2023-06-30 | $29.00K 10-Q · filed 2024-11-06 | |
| 2022-06-30 | $28.00K 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $17.00K 10-Q · filed 2023-11-08 | |
| 2021-12-31 | $358.00K 10-K · filed 2023-03-08 | |
| 2021-09-30 | $268.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $31.00K 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $29.00K 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $34.00K 10-K · filed 2022-03-23 | |
| 2020-09-30 | $12.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $2.00K 10-Q · filed 2021-11-10 | |
| 2020-03-31 | $3.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |